Bulletin
Investor Alert

Sanofi

OTC: SNYNF

GO
/marketstate/country/us

Market closed

 --Quotes are delayed by 20 min

Sep 26, 2022, 11:21 a.m.

/zigman2/quotes/205505035/delayed

$

75.83

Change

+2.47 +3.37%

Volume

Volume 168,782

Quotes are delayed by 20 min

/zigman2/quotes/205505035/delayed

Previous close

$ 73.36

$ 75.83

Change

+2.47 +3.37%

Day low

Day high

$73.31

$77.59

Open

52 week low

52 week high

$73.31

$112.50

Open

Annual Financials for Sanofi

Operating Activities

Fiscal year is January-December. All values EUR millions. 20172018201920202021 5-year trend
Net Income before Extraordinaries 8.42B4.31B2.81B12.29B6.22B
Depreciation, Depletion & Amortization 3.12B3.44B3.72B3.26B3.12B
Depreciation and Depletion 1.12B1.14B1.42B1.44B1.38B
Amortization of Intangible Assets 2B2.3B2.3B1.82B1.74B
Deferred Taxes & Investment Tax Credit (909M)(727M)(1.75B)(221M)(356M)
Deferred Taxes (909M)(727M)(1.75B)(221M)(356M)
Investment Tax Credit -----
Other Funds (3.39B)(192M)3.39B(7.59B)126M
Funds from Operations 7.23B6.83B8.16B7.74B9.11B
Extraordinaries -----
Changes in Working Capital 147M(1.28B)(419M)(325M)1.41B
Receivables (529M)(35M)(462M)(134M)185M
Accounts Payable 577M270M169M86M451M
Other Assets/Liabilities 243M(814M)421M316M1.13B
Net Operating Cash Flow 7.38B5.55B7.74B7.42B10.52B

Investing Activities

20172018201920202021 5-year trend
Capital Expenditures (1.96B)(1.98B)(1.82B)(2.2B)(2.11B)
Capital Expenditures (Fixed Assets) (1.96B)(1.98B)(1.82B)(2.08B)(2.04B)
Capital Expenditures (Other Assets) ---(113M)(68M)
Net Assets from Acquisitions (1.19B)(12.93B)(495M)(5.34B)(5.59B)
Sale of Fixed Assets & Businesses 535M2.16B1.22B918M718M
Purchase/Sale of Investments (61M)(137M)(38M)10.23B(311M)
Purchase of Investments (61M)(137M)(38M)(137M)(311M)
Sale/Maturity of Investments ---10.37B-
Other Uses (263M)(64M)(94M)--
Other Sources 3.54B-154M--
Net Investing Cash Flow 602M(12.95B)(1.07B)3.62B(7.3B)

Financing Activities

20172018201920202021 5-year trend
Cash Dividends Paid - Total (3.71B)(3.77B)(3.83B)(3.94B)(4.01B)
Common Dividends (3.71B)(3.77B)(3.83B)(3.94B)(4.01B)
Preferred Dividends -----
Change in Capital Stock (1.84B)(924M)153M(619M)(196M)
Repurchase of Common & Preferred Stk. (2.16B)(1.1B)(9M)(822M)(382M)
Sale of Common & Preferred Stock 319M177M162M203M186M
Proceeds from Stock Options 319M177M162M203M186M
Other Proceeds from Sale of Stock -----
Issuance/Reduction of Debt, Net (2.3B)8.72B(224M)(1.65B)(2.66B)
Change in Current Debt 30M(168M)(154M)282M(414M)
Change in Long-Term Debt (2.33B)8.89B(70M)(1.93B)(2.24B)
Issuance of Long-Term Debt 41M9.68B2B2.02B-
Reduction in Long-Term Debt (2.37B)(787M)(2.07B)(3.95B)(2.24B)
Other Funds (15M)(14M)(14M)(44M)(48M)
Other Uses (15M)(14M)(14M)(44M)(48M)
Other Sources -----
Net Financing Cash Flow (7.87B)4.01B(4.19B)(6.49B)(7.06B)
Exchange Rate Effect (74M)1M9M(64M)15M
Miscellaneous Funds -----
Net Change in Cash 42M(3.39B)2.5B4.49B(3.82B)
Free Cash Flow 5.42B3.57B5.93B5.34B8.48B
Link to MarketWatch's Slice.